Bifogade filer
PDF
Kurs
+2,95%
Likviditet
0,41 MSEK
Kalender
| Tid* | ||
| 2025-06-03 | 07:00 | Bokslutskommuniké 2025 |
| 2025-03-03 | 07:00 | Kvartalsrapport 2025-Q3 |
| 2025-01-20 | N/A | Extra Bolagsstämma 2025 |
| 2024-12-04 | - | Kvartalsrapport 2025-Q2 |
| 2024-09-26 | - | X-dag ordinarie utdelning INTEG B 0.00 SEK |
| 2024-09-25 | - | Årsstämma |
| 2024-08-29 | - | Kvartalsrapport 2025-Q1 |
| 2024-05-30 | - | Bokslutskommuniké 2024 |
| 2024-02-29 | - | Kvartalsrapport 2024-Q3 |
| 2023-12-04 | - | Kvartalsrapport 2024-Q2 |
| 2023-10-04 | - | X-dag ordinarie utdelning INTEG B 0.00 SEK |
| 2023-09-27 | - | Årsstämma |
| 2023-08-31 | - | Kvartalsrapport 2024-Q1 |
| 2023-06-08 | - | Bokslutskommuniké 2023 |
| 2023-03-01 | - | Kvartalsrapport 2023-Q3 |
| 2022-12-01 | - | Kvartalsrapport 2023-Q2 |
| 2022-10-03 | - | X-dag ordinarie utdelning INTEG B 0.00 SEK |
| 2022-09-28 | - | Årsstämma |
| 2022-08-31 | - | Kvartalsrapport 2023-Q1 |
| 2022-06-10 | - | Bokslutskommuniké 2022 |
| 2022-03-02 | - | Kvartalsrapport 2022-Q3 |
| 2021-12-02 | - | Kvartalsrapport 2022-Q2 |
| 2021-09-09 | - | X-dag ordinarie utdelning INTEG B 0.00 SEK |
| 2021-09-02 | - | Kvartalsrapport 2022-Q1 |
| 2021-05-31 | - | Bokslutskommuniké 2021 |
| 2021-03-03 | - | Kvartalsrapport 2021-Q3 |
| 2020-12-02 | - | Kvartalsrapport 2021-Q2 |
| 2020-09-30 | - | Årsstämma |
| 2020-09-09 | - | X-dag ordinarie utdelning INTEG B 0.00 SEK |
| 2020-08-24 | - | Kvartalsrapport 2021-Q1 |
| 2020-06-08 | - | Bokslutskommuniké 2020 |
| 2020-04-20 | - | Extra Bolagsstämma 2020 |
| 2020-03-02 | - | Kvartalsrapport 2020-Q3 |
| 2019-12-02 | - | Kvartalsrapport 2020-Q2 |
| 2019-09-30 | - | Årsstämma |
| 2019-09-25 | - | X-dag ordinarie utdelning INTEG B 0.00 SEK |
| 2019-09-02 | - | Kvartalsrapport 2020-Q1 |
| 2019-06-10 | - | Bokslutskommuniké 2019 |
| 2019-03-04 | - | Kvartalsrapport 2019-Q3 |
| 2018-12-17 | - | Kvartalsrapport 2019-Q2 |
| 2018-09-25 | - | X-dag ordinarie utdelning INTEG B 0.00 SEK |
| 2018-09-24 | - | Årsstämma |
| 2018-09-24 | - | Kvartalsrapport 2019-Q1 |
| 2018-06-25 | - | Bokslutskommuniké 2018 |
| 2018-03-26 | - | Kvartalsrapport 2018-Q3 |
| 2017-12-18 | - | Kvartalsrapport 2018-Q2 |
| 2017-09-25 | - | Årsstämma |
| 2017-09-25 | - | Kvartalsrapport 2018-Q1 |
| 2017-06-30 | - | Bokslutskommuniké 2017 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Mölndal, Sweden, October 17[th], 2022 - Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announced that the company has received ISO 13485 certification for medical devices from BSI Group the Netherlands B.V. The certification is an external validation of Integrum's long-term efforts to secure a high level of internal quality control.
ISO 13845 is an international standard designed to be used by organizations involved in the design, production, installation and servicing of medical devices and related services. The ISO 13485 certificate confirms that Integrum's quality management system meets the most current regulatory requirements for the medical device industry.
"Having a best-in-class quality management system is fundamental in our ongoing international expansion. This certificate is yet another proof that Integrum has well-established processes in place to meet regulatory requirements in all parts of the world," comments Rickard Brånemark, CEO of Integrum.
Rickard Brånemark, CEO. +46 (0) 70 846 10 61, E-mail: rickard.branemark@integrum.se
Dennis Baecklund, CFO. +46 (0) 72 556 68 69, E-mail: dennis.baecklund@integrum.se
Certified Adviser
Erik Penser Bank is Certified Adviser and can be reached at +46 (0) 8-463 8000.